
Continued process verification ensures pharmaceutical manufacturing stays in control through data analysis, trend detection, and lifecycle monitoring.
Philip Hoersch is Director, Quality Assurance, Process Performance & System Compliance, Vetter.
Continued process verification ensures pharmaceutical manufacturing stays in control through data analysis, trend detection, and lifecycle monitoring.
The author reviews operative options for the implementation of a quality oversight and how companies can benefit from this function from a regulatory perspective.
Published: March 15th 2018 | Updated: